Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer
Brianna Hoffner, Natasha B. Leighl, Marianne Davies
Topics & Concepts
MedicineNivolumabPembrolizumabAtezolizumabLung cancerChemotherapyOncologyInternal medicineImmunotherapyCancerCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations